
Molecular Precision
Elixis Biosciences
Strategic Advisory, IP Generation & Technology Evaluation in Drug Delivery Science
We bridge the gap between advanced pharmaceutical chemistry and consumer wellness. Elixis provides rigorous technical due diligence, formulation architecture, and develops novel intellectual property to solve current unmet needs in both next-generation therapeutics and functional wellness.
Driven by Molecular Precision. Guided by the Orthovert Ethos.
At Elixis Biosciences, we do not rely on trial-and-error formulation. We treat product development as an integrated system, applying the same rigor used in advanced biopharma to both therapeutic and consumer applications. Our methodology is built on three core tenets:

01
Target Product Profile (TPP) Engineering
We start with the ultimate clinical or commercial endpoint and engineer the formulation backward, ensuring every excipient serves a distinct functional purpose.
02
Bayesian Adherence
We build formulations around a data-driven framework, relentlessly updating our technical priors as new analytical data emerges to optimize bioavailability and stability.
03
Bio-Inspired Design
Taking cues from biological systems to solve complex barrier problems, from mucosal penetration to sustained transdermal flux.
Core Advisory Pillars
Executive-Level Consulting & IP Generation
01
Novel IP Development for Unmet Needs
We don't just evaluate existing technologies; we architect the future. Elixis actively develops new, licensable intellectual property designed to overcome current unmet clinical and commercial barrier problems—giving our partners a definitive competitive moat.
02
Strategic Due Diligence & Tech Evaluation
Providing investors, biopharma, and accelerators with unvarnished technical evaluations. We assess the viability, scalability, and intellectual property strength of emerging drug delivery platforms before you commit capital.
03
Translational Formulation Architecture
Guiding the rational design of complex delivery systems using Quality by Design (QbD) principles. We advise on optimizing non-viral delivery architectures, maximizing encapsulation efficiency, and bypassing first-pass metabolism.
04
The Consumer Wellness Program
Translating rigorous pharmaceutical science into the commercial market. Through our dedicated Consumer Wellness Program, we architect formulation strategies for low-sugar, high-satiety functional gummies, advanced sublingual films, and cosmetic oral care systems using scientifically validated actives.
Technical Focus Areas
Lipid Nanoparticles (LNPs)
Advisory on structural optimization for enhanced cellular uptake, superior stability, and targeted payloads.
Transmucosal & Nasal Systems
Engineering spontaneous micro-emulsification strategies for rapid systemic absorption and CNS delivery.
Transdermal Platforms
Matrix and reservoir design strategies utilizing advanced permeation enhancers for sustained flux.
Precision Oral & Sublingual
Mucoadhesive matrix consulting for rapid transmucosal kinetics and precise dosing.